EA202092895A1 - AGONISTIC ANTIBODIES AGAINST CD226 - Google Patents

AGONISTIC ANTIBODIES AGAINST CD226

Info

Publication number
EA202092895A1
EA202092895A1 EA202092895A EA202092895A EA202092895A1 EA 202092895 A1 EA202092895 A1 EA 202092895A1 EA 202092895 A EA202092895 A EA 202092895A EA 202092895 A EA202092895 A EA 202092895A EA 202092895 A1 EA202092895 A1 EA 202092895A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibodies against
agonistic antibodies
agonistic
useful
treatment
Prior art date
Application number
EA202092895A
Other languages
Russian (ru)
Inventor
Нареш Кумар
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Priority claimed from PCT/US2019/042604 external-priority patent/WO2020023312A1/en
Publication of EA202092895A1 publication Critical patent/EA202092895A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Данное изобретение относится к агонистическим антителам против CD226 человека, которые могут быть полезны для лечения солидных раковых опухолей.This invention relates to agonist antibodies against human CD226, which may be useful for the treatment of solid cancers.

EA202092895A 2019-01-23 2019-07-19 AGONISTIC ANTIBODIES AGAINST CD226 EA202092895A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962795744P 2019-01-23 2019-01-23
PCT/US2019/042604 WO2020023312A1 (en) 2018-07-26 2019-07-19 Cd226 agonist antibodies

Publications (1)

Publication Number Publication Date
EA202092895A1 true EA202092895A1 (en) 2021-04-23

Family

ID=75817439

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092895A EA202092895A1 (en) 2019-01-23 2019-07-19 AGONISTIC ANTIBODIES AGAINST CD226

Country Status (1)

Country Link
EA (1) EA202092895A1 (en)

Similar Documents

Publication Publication Date Title
PH12021550337A1 (en) Anti-gdf15 antibodies, compositions and methods of use
MX2020012797A (en) Anti-pvrig/anti-tigit bispecific antibodies and methods of use.
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
CO2020013392A2 (en) Chimeric dll3 receptors and methods for their use
EA201891202A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201891201A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890131A1 (en) IMMUNOMODULATION AND TREATMENT OF SOLID TUMORS BY ANTIBODIES THAT SPECIFICALLY CONNECT CD38
EA201890050A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890049A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201692201A1 (en) CONNECTIONS AND COMPOSITIONS AS AN AGONISTS OF TOLL-LIKE RECEPTOR 7
EA202090204A1 (en) ANTI-CD137 ANTIBODIES
EA201890175A1 (en) ANTIBODIES TO CD40
EA202091130A1 (en) LYOPHILIZED PREPARATION OF MONOCLONAL ANTIBODY TO TRANSTYRETIN
NZ760841A (en) Agonist antibodies that bind human cd137 and uses thereof
EA202190609A1 (en) ANTIBODIES AGAINST HLA-G, COMPOSITIONS CONTAINING ANTIBODIES AGAINST HLA-G, AND METHODS OF APPLICATION ANTIBODIES AGAINST HLA-G
EA201792055A1 (en) ANTIBODIES AGAINST CD48 AND THEIR CONJUGATES
MX2018009325A (en) Compounds and methods of treating rna-mediated diseases.
MX2020013630A (en) Rapamycin analogs and uses thereof.
EA201792561A1 (en) ANTIBODIES AIMED ON MORPHOGENETIC BONE 9 PROTECTION (BMP9) AND METHODS OF THEIR APPLICATION
EA201892005A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
MX2019001979A (en) PPARy AGONIST FOR TREATMENT OF BLOOD CANCERS.
EA201891528A1 (en) COMPOSITIONS AND METHODS OF DETECTION AND TREATMENT OF GASTRIC CANCER
PH12019502694A1 (en) Anti-trkb antibodies
EA201992315A1 (en) COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER
BR112017020374A2 (en) fused bicyclic compounds for the treatment of disease